Podcasts about oregon health

Brooke Beckett, MD, is a Radiologist and the Director of the Residency Program at Oregon Health and Science University. In Part 2, we look at a radiograph and discuss basics of appearance of air, fat, tissue, bone and metal. What do you tell patients who are worried about radiation for a CT scan or xray?

Brooke Beckett, MD, is a Radiologist and the Director of the Residency Program at Oregon Health and Science University. In Part 1 of her interview, she discusses with Chuck and Miles some important core concepts for reading radiographs and ordering images in general.

Since humans first chiseled marks into stone, we have externalized our thoughts and ideas. Our tools may have evolved—now we clack away at computer keyboards—but written communication remains a bedrock of modern society. Now that the pace of information creation is exponentially increasing with the advent of artificial intelligence, many are asking what the next frontier of human communication may look like. We look at how we got here, where the latest tools are headed—including brain-machine-interface—and how our brains and culture may be altered in the process. Guests: Alex Bentley – professor of anthropology, archeology, and computational social science at University of Tennessee in Knoxville, and co-author of “Collaborators Through Time: How Humans Partnered with Nature, Technology, and Each Other”  Michael O'Brien – anthropologist at the Texas A&M University, San Antonio, and co-author of “Collaborators Through Time: How Humans Partnered with Nature, Technology, and Each Other”  Tom Mullaney – professor of Chinese history at Stanford University, and author of “The Chinese Computer: A Global History of the Information Age” Betts Peters – Brain computer interface researcher at Oregon Health and Science University, treasurer of the Brain Computer Interface Society Big Picture Science is part of the Airwave Media podcast network. Please contact advertising@airwavemedia.com to inquire about advertising on Big Picture Science. You can get early access to ad-free versions of every episode by joining us on Patreon. Thanks for your support! Learn more about your ad choices. Visit megaphone.fm/adchoices

Since humans first chiseled marks into stone, we have externalized our thoughts and ideas. Our tools may have evolved—now we clack away at computer keyboards—but written communication remains a bedrock of modern society. Now that the pace of information creation is exponentially increasing with the advent of artificial intelligence, many are asking what the next frontier of human communication may look like. We look at how we got here, where the latest tools are headed—including brain-machine-interface—and how our brains and culture may be altered in the process. Guests: Alex Bentley – professor of anthropology, archeology, and computational social science at University of Tennessee in Knoxville, and co-author of “Collaborators Through Time: How Humans Partnered with Nature, Technology, and Each Other”  Michael O'Brien – anthropologist at the Texas A&M University, San Antonio, and co-author of “Collaborators Through Time: How Humans Partnered with Nature, Technology, and Each Other”  Tom Mullaney – professor of Chinese history at Stanford University, and author of “The Chinese Computer: A Global History of the Information Age” Betts Peters – Brain computer interface researcher at Oregon Health and Science University, treasurer of the Brain Computer Interface Society Big Picture Science is part of the Airwave Media podcast network. Please contact advertising@airwavemedia.com to inquire about advertising on Big Picture Science. You can get early access to ad-free versions of every episode by joining us on Patreon. Thanks for your support! Learn more about your ad choices. Visit megaphone.fm/adchoices

Lavon Medlock has spent over two decades enhancing leaders' skills in problem-solving and coaching. Skilled in a variety of continuous improvement methods, she has trained leaders in creating effective daily management systems, deployed an integrated facility design approach to new construction projects like a 90,000-square-foot patient tower, and enhanced operations across different sectors.With a primary focus on the healthcare industry, Lavon has worked with clinical leaders to combine the Institute of Healthcare Improvement's teachings on quality with A3 thinking and key project management principles. She's a practitioner, teacher, and coach in the field of A3 thinking and holds certifications in both Project Management (PMI-PMP) and Six Sigma Green Belt.In addition to instructing and coaching for the Lean Enterprise Institute, she teaches graduate coursework at The Ohio State University. Her educational background includes a Bachelor of Science in Public Health from the University of North Carolina at Chapel Hill and a Master of Science in Healthcare Administration from Oregon Health & Science University.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

In this episode of Genetics in Your World, GSA Early Career Scientists Multimedia Subcommittee member Luke Arnce interviews Caitlin Peaslee of the Center for Embryonic Cell and Gene Therapy at Oregon Health and Science University about her research. Read her paper titled, "Mapping whole-organism genetic comorbidities across model species using unified ontologies," published in the April 2026 issue of GENETICS: https://doi.org/10.1093/genetics/iyag038 This study developed a cross-species computational framework, CoMo DBM, to analyze 204 mouse genes that caused non-obstructive azoospermia and mapped their phenotype associations across human, zebrafish, fruit fly, and roundworm databases. Music: Loopster Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 License, http://creativecommons.org/licenses/by/3.0/#GeneEditing #cancer #GeneOntology Hosted on Acast. See acast.com/privacy for more information.

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Charles D. Blanke, MD, FACP, FASCO, a professor of medicine in the School of Medicine at the Oregon Health & Science University (OHSU) Knight Cancer Institute in Portland.Drs Camidge and Blanke discuss Dr Blanke's unique career path from pioneering targeted cancer therapies to becoming a leading advocate for medical aid in dying. A Type 1 diabetes diagnosis directed Dr Blanke toward an interest in internal medicine and oncology. During his fellowship and early faculty days, he established a reputation for his hard work pursuing research opportunities, even when initial projects were unsuccessful.Blanke's most transformative scientific achievement occurred at OHSU, where he spearheaded the use of Imatinib (Gleevec) for the management of gastrointestinal stromal tumor (GIST). By targeting the KIT mutation, this research turned a previously untreatable malignancy into one with a high response rate, marking a landmark moment for personalized oncology.Equally significant in Dr Blanke's career is his role in medical aid in dying. Practicing in Oregon, the first state to legalize the option, he has written hundreds of prescriptions for patients with terminal diseases. Blanke views medical aid in dying as a vital extension of patient care.As the former chair of SWOG, Dr Blanke modernized clinical research by introducing term limits, increasing access to clinical trials among, and championing the development of pragmatic trials with broader patient eligibility criteria. Throughout his tenure, he emphasized the importance of patient advocacy and the altruistic nature of cooperative research. Having recently stepped down from his leadership at SWOG, he intends to focus his future efforts on patient rights and medical aid in dying advocacy.

 It’s estimated that 1 in 10 adults experience tinnitus, often described as a phantom ringing noise in the ears. The condition can develop due to head trauma, hearing loss, exposure to loud noise or as a side effect of certain medications.   There’s no cure for tinnitus and its origins have long been a mystery. But new research from Oregon Health & Science University has linked tinnitus with elevated serotonin levels in certain regions of the brain. While far from a cure, the discovery could one day help scientists understand how to reverse the condition through brain chemistry.   Larry Trussell is a professor of otolaryngology at OHSU and interim director of the Oregon Hearing Research Center. Angie Garinis is an associate professor of otolaryngology at OHSU and a member of the Oregon Hearing Research Center. She’s also a principal investigator at the National Center for Rehabilitative Auditory Research at the Portland VA.   They both join us to talk about what this new information could mean for patients who suffer from tinnitus.  

In 2024 Novo Nordisk announced it would discontinue Levimir insulin.. leaving many people scrambling and kind of stunned. There's no other insulin on the market quite like this long-acting – and it turns out the community wasn't letting it go without a fight. My guests are going to tell you more about why. I'm taking to Alison Smart, founder of The Alliance to Protect Insulin Choice – her daughter lives with type 1 as well as two doctors: Florence Brown and Amy Valent. Dr. Brown is Co-Director Joslin and BIDMC Diabetes in Pregnancy Program, Assistant Professor of Medicine, Harvard Medical School. Dr. Valent Assistant Professor of Obstetrics and Gynecology, School of Medicine at Oregon Health and Science University. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com 

Hey Tinnitus Friends & Family, A new study from Oregon Health & Science University found a direct brain circuit linking serotonin to tinnitus symptoms. If you're taking antidepressants and have tinnitus, you've probably seen the headlines—and maybe felt some panic. Here's the truth: this is good science, not a reason to stop your medication. In this video, I break down what the research actually found, why mouse studies can't tell the whole story, and what this means if you're currently taking SSRIs. I also share my personal experience—I take SSRIs myself, and they haven't worsened my tinnitus. **Key Takeaways:** ✅ The study found a serotonin → auditory circuit that can create tinnitus-like behavior in mice ✅ This validates what some people report, but doesn't mean SSRIs "cause" tinnitus ✅ SSRIs can be life-changing for depression and anxiety—the benefits often far outweigh risks ✅ Never stop medication without talking to your doctor ✅ Habituation works regardless of whether you're on medication **Timestamps:** 0:00 Introduction: Who I Am (and Who I'm Not) 1:15 Why This Research Matters 2:20 What Are SSRIs? 3:40 The Study Explained: Serotonin → Auditory Circuit 5:10 How the Research Was Done (Optogenetics) 6:30 What Dr. Trussell Said About Future Treatments 7:45 My Take: What This Means for YOU 9:20 My Personal Experience with SSRIs 10:15 Bottom Line: Talk to Your Doctor 11:00 You Don't Have to Do This Alone **Resources Mentioned:**

Scientists at Oregon Health & Science University’s Knight Cancer Institute are pioneering a new way to study cancer that could lead to faster cancer detection and more targeted treatment. It involves 3D printing cancer cells from a patient and miniature versions of organs like bones and lungs. The healthy tissue and cancer cells are placed together inside a tiny device that’s roughly the size of a thumbdrive. Scientists can then observe in real time how they interact and discover ways to halt the cancer’s spread into the healthy tissue.    Luiz Bertassoni is the director of the institute’s Precision Biofabrication Hub, which he helped launch in 2023, and a professor of oncology at OHSU. Since last year, he and his team have received more than $9 million in funding from the National Institutes of Health to advance the potential of these so-called organ-on-a-chip devices in the fight against cancer. The latest grants target an aggressive form of prostate cancer that spreads to bones and a cancer of the bone that spreads to lungs. Bertassoni joins us to talk about this new technology and the promise he thinks it holds for the roughly 40% of adults in the U.S. who will likely develop cancer at some point in their lives.   

Harmonizing Process and Policy Large, multi-facility healthcare systems, sometimes spread across several counties or states, pose unique challenges for Sterile Processing (SP) leaders. Competing state and local regulations as well as physical constraints of space, conflicting priorities and different operating hours can make it challenging to harmonize policies and procedures across sites. In episode 148, host Casey Czarnowski speaks with Stacey MacArthur, an SP professional with 35 years of experience and current member of the HSPA Board of Directors, about working effectively in a multi-facility system. MacArthur explains the importance of choosing to collaborate with other stakeholders, including fellow SP leaders and colleagues in Infection Prevention, Quality, and Risk Management. She reviews projects that have benefited from system-wide standardization and their associated challenges. Listen to learn strategies to work smarter, prioritize important tasks (not just urgent ones), and speak with leadership about change, all with the goals of achieving compliance and supporting sustainable outcomes. Guest Speaker: Stacey MacArthur Director of Central Sterile Processing Oregon Health and Science University Stacey MacArthur, MS, CRCST, CER, CIS, CHL, started her Sterile Processing career at the tender age of 19. She has worked in a variety of SP roles and is currently the Director of Central Sterile Processing at Oregon Health and Science University based in Portland. She earned her bachelor's degree in business administration and a master's degree in organizational leadership from Warner Pacific University. MacArthur has served on the Cascade chapter board since 2016 and is the chapter's current President. She also serves on the HSPA Board of Directors. MacArthur is passionate about our industry and strives to elevate and empower the professionals who do this life-saving work. Earn CE Now

Welcome back to the AI journal club! In this episode, we bring you a deep dive into a game-changing paper from The Lancet -- the MASAI study. This is the first randomized controlled trial to evaluate the use of artificial intelligence in breast cancer screening and we're so excited to discuss it.We'll break down the study's impressive findings on interval cancer rates, sensitivity, and massive workload reductions for radiologists. Beyond the data, we'll tackle the big-picture questions and some sensational recent headlines. Are we deploying AI too fast? Or is it time to go faster? Hosts: - Ayman Ali, MDAyman Ali is a Behind the Knife fellow and general surgery PGY-4 at Duke Hospital in his academic development time where he focuses on data science, artificial intelligence, and surgery. - Ruchi Thanawala, MD: @Ruchi_TJRuchi Thanawala is an Associate Professor of Informatics and Thoracic Surgery at Oregon Health and Science University (OHSU) and founder of Firefly, an AI-driven platform that is built for competency-based medical education. In addition, she is the Director of the Surgical Data and Decision Sciences Lab for the Department of Surgery at OHSU and Associate Program Director for the Clinical Informatics Sub-specialty Fellowship. - Phillip Jenkins, MD: @PhilJenkinsMDPhil Jenkins is a general surgery PGY-4 at Oregon Health and Science University and a National Library of Medicine Post-Doctoral fellow pursuing a master's in clinical informatics.***Fellowship Application Link: https://forms.gle/QSUrR2GWHDZ1MmWC6Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewOral Board Simulator: https://app.behindtheknife.org/oral-board-simulatorTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Access to preschool in Oregon remains limited, with more than half of the state’s school districts reporting that demand has outpaced available slots. The deficit could leave many children without the early literacy and math skills they’re expected to bring into kindergarten.    The Kinder Coaching Program at Oregon Health & Science University aims to incorporate school readiness into medical care. During a routine visit, medical providers can refer children on Medicaid to a team of community health workers who help them develop the cognition, communication and social-emotional skills they need for kindergarten.     Jaime Peterson is a pediatrician at OHSU and director of the Kinder Coaching Program. Isha Syll is a certified community health worker and one of the program’s “kinder coaches.” They both join us to talk about the importance of providing early learning opportunities for low-income families.  

“IR wasn't initially a specialty—it was just a diagnostic tool. Dotter began to think of it as more than a tool.” — John A. Kaufman, MD, FSIROn this episode of the Kinked Wire, Alden Davis of Oregon Health and Sciences University School of Medicine speaks with John A. Kaufman, MD, FSIR, on the legacy of the Dotter Institute at OHSU and the future of IR education. SIR thanks Medtronic for its generous support of the Kinked Wire.Contact us with your ideas and questions, or read more about interventional radiology in IR Quarterly magazine or SIR's Patient Center. Senior Editorial Manager, Hope Racine, explains the work she does at SIR.Support the show

Kent Thornburg is a Professor of Medicine Emeritus at Oregon Health and Science University. But he is far from retired. He’s actively promoting the research he and others have done into the Developmental Origins of Health and Disease. Thornburg coined the phrase “the 100 year effect” to describe how “early life environment” before and during  pregnancy can affect the lifetime risks of chronic diseases — and how those effects can actually be traced to not just  not just to both parents, but grandparents as well.   A new documentary about both the research, and Thornburg’s unconventional campaign meant to galvanize people and communities to spread the word about this research premiered at OHSU on March 20. The date was chosen in conjunction with the National Future Generations Day. “The 100 Year Effect” is now available to view free of charge by request for individuals or community screenings on the film website. Thornburg says the only way anything will change is if young people and community leaders get energized and motivated. That’s where people like Kelsey Mueller Wendt come in. She is herself a young mother and the coordinator for the Nutrition Oregon Campaign Hub in Klamath Falls. Mueller Wendt and Thornburg join us to share more about larger education campaign and the film, which is both a showcase and an invitation into the larger effort to eliminate chronic disease.

The Alzheimer’s Foundation of America is holding a free one-day conference in Portland on Wednesday designed for patients, families and caregivers. One of the keynote speakers is the co-director of the state’s only Alzheimer’s Disease Research Center, Oregon Health and Science University’s Kevin Duff. He says early detection recommendations have changed over recent years and with the emergence of new drugs, many early stage patients can experience dramatically improved outcomes — so catching the disease early is critically important. Duff joins us in studio to discuss the details.

Manager's note: The Pain Beat, launched and supported by a generous grant from the MAYDAY Fund, with additional funding from the Rita Allen Foundation, brings together the world's leading pain investigators with the purpose of sparking dialogue and debate around important ideas in pain research. Guided by Lite Yang, Scientific Director and co-producer, and Rebecca Seal, Chair Editorial Board of PRF, the podcasts feature open and spirited discussions about the hottest topics in pain and how the field moves forward. Here we dive into a topic that's both surprisingly complex and often overlooked—eye pain. Our eyes are among the most sensitive structures in the human body, yet the mechanisms behind ocular pain remain poorly understood. In this episode, we have the pleasure hosting clinicians who are treating patients with eye pain every day speak with their colleagues and collaborators, who are preclinical pain researchers working to unravel the underlying biology. What emerged was a fascinating conversation about the different types and distinct mechanisms driving eye pain. Our guests explored the organ's intricate structures and their relationships to sensation as well as the role of different brain regions in shaping how we ultimately perceive and experience ocular discomfort. Dr. Sue Aicher, Ph.D., Oregon Health and Science University, Dr. Anna Matynia, Ph.D. University of Houston college of Optometry, Dr. Brooke Harkness, O.D., M.S., FAAO, Casey Eye Institute, Oregon Health and Science University, Dr. Lindsey Delott, M.D., University of Michigan Kellogg Eye Center Dr. Anat Galor, M.D., M.S.P.H., Bascom Palmer Eye Institute at University of Miami, Moderator was Dr. Sejiro Littleton, Ph.D., Duke University This episode was produced by Lite Yang, and edited by Dieu Ni Daon.  Music by Kevin Seal of Seal Party.

Holly O'Dell, President & CEO of Montana State Fund, joins host James Benham to discuss how systems thinking, people-first leadership, and strategic clarity are transforming workers' compensation — from inside a mission-driven organization that competes and wins in a fully open market. Holly brings a rare combination of credentials to the role: a BSN from Oregon Health & Science University, a JD from Lewis & Clark College, and an MBA from the Wharton School.Before joining Montana State Fund in 2022, she spent nearly 17 years at SAIF Corporation in Oregon, rising from trial attorney to VP of Strategy, Government Relations, Legal, and Procurement. Montana State Fund covers more than 60% of Montana's workers' comp market — in a fully competitive environment where they earn every dollar.In this episode:- Why risk tolerance is the real foundation of innovation — and how to build it before anything else- How Montana State Fund reduced 27,000 annual policy cancellations by two-thirds — without a single new technology- The people-first shift that brought claims turnover from 40% down to 4.5%- Building a culture where frontline employees have genuine FOMO about AI and innovation projects- What it means to be strategic in an industry full of shiny objects- The world's first workers' comp regulatory sandbox — and what it could unlockKey Quotes:"I'm not into norming. I'm into storming.""Risk is an opportunity for gain or for a loss.""Nonprofit is not a business model.""Strategy is an integrated set of choices.""This is an industry worth hanging out in."Timestamps:07:53 — The 20-sided dice: why insurance attracts multi-disciplinary thinkers15:12 — "I'm not into norming. I'm into storming." — Holly's leadership philosophy19:30 — Cancel cancellations: solving a 27,000-policy problem without technology23:57 — From 40% turnover to 4.5% — the people transformation at Montana State Fund27:04 — The FOMO effect: building a culture where everyone wants in on AI35:51 — Firefighter training injuries reduced from 50% to zero — the predict-and-prevent model in action

Morgellons disease has been searched more in Portland, Oregon than any other city on Earth for 22 consecutive years according to Google Trends data from 2004 to present. Portland scores 100 on the search interest index. Seattle is second at 86. Boca Raton Florida third at 80. By country the United States leads at 100, Canada 76, Austria 57, Italy 53, Germany 50.No published paper on Morgellons disease has ever investigated the geographic clustering of cases in Portland Oregon. This episode asks why.Jesse Keller MD at Oregon Health and Science University OHSU is the only researcher in the United States conducting molecular bench science on Morgellons tissue. His 2023 paper in Archives of Dermatological Research found elevated oncostatin M expression in lesional skin biopsies of Morgellons patients compared to healthy controls. Oncostatin M is an inflammatory cytokine known to sensitize pain and itch neurons. His 2024 paper in British Journal of Dermatology documented that Morgellons patients report lower quality of life than patients with psoriasis atopic dermatitis and prurigo nodularis. Keller was featured on OPB Think Out Loud on March 10 2026 discussing Morgellons disease.Referenced research: Keller Liu Latour 2023 Archives of Dermatological Research. Gipple Latour Keller Dhami 2024 British Journal of Dermatology. Pearson Vuolo Freire Merritt Klotter Maughan Montanez Amobi Middleton Dahlgren 2012 PLoS One CDC unexplained dermopathy study. Beuerlein Balogh Feldman 2021 Dermatology Online Journal. Akbarialiabad Salehi Murrell Jafferany 2025 Archives of Dermatological Research confirming zero randomized controlled trials exist for Morgellons treatment.More Morgellons podcast. Hosted by Summer. Over 400 episodes heard in 100 plus countries. Top 5 percent on Listen Notes. Available on all major podcast platforms.Website to leave CC a VM is www.moremorgellons.com

 Morgellons disease is a rare skin condition described by intense itching, burning and crawling sensation underneath the skin. Many living with the condition also experience painful sores and, as a 2024 study found, have a lower quality of life. Oregon Health and Science University Dermatologist Jesse Keller is one of the authors of that study. He was also recently featured in an article about the condition in Undark. Keller joins us to share more on what Morgellons disease is and what he hears from the patients he treats.  

National guidelines recommend a routine screening for anxiety and intimate partner violence in adolescent girls and women. But the screenings are rarely implemented across clinics in Oregon, according to a new study from Oregon Health and Science University.    The study cites reasons such as provider discomfort, lack of awareness and challenges to workflow as reasons these screenings aren’t being implemented. Amy Cantor, a researcher and OHSU family physician, was the senior researcher on this study. She joins us to share her findings and how the research led to new, tangible tools that providers can use in the screening process.  

CAR T‑cell therapy is redefining what personalized cancer treatment can look like, offering real promise for patients and families. In this episode, we speak with Dr. Richard Maziarz and CAR T Nurse Coordinator Bashi Ratterree of Oregon Health & Science University (OHSU). Together, they explain how CAR T‑cell therapy works, who may be eligible, what patients can expect during treatment and recovery, and the promising advancements shaping the future of this innovative therapy. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: CAR T-cell therapy Clinical Trial Support Center CAR T-Cell Therapy: A Path of Hope and Healing Video Series Bloodline Breakthroughs: innovations and inspiration video podcast: CAR T-cell Therapy Hematology Horizons vlog: CAR T-Cell Therapy and the Patient Experience CAR T-Cell Therapy: Side Effects video Additional Blood Cancer United Support Resources: Information Specialists Financial support Online Chat Free Nutrition Consultations Free telephone/web patient programs Free booklets Young Adult Resources Support groups Caregiver support Caregiver Workbook Survivorship Workbook Advocacy and Public Policy Patient Community Mental Health Resources Episode supported by Bristol Myers Squibb; Johnson & Johnson & Legend Biotech; Kite, a Gilead Company; Novartis Pharmaceuticals Corporation. The post Inside CAR T‑Cell Therapy: How Innovation Is Changing Lives first appeared on The Bloodline with Blood Cancer United Podcast.

Earlier this month, Oregon Health and Science University released new nationwide data that found low physician participation in Medicaid.  Researchers deemed these physicians “ghost” providers: physicians who are enrolled in Medicaid, but don’t care for even a single patient covered by the federal health insurance program. Those findings also revealed that another third of physicians who are enrolled in Medicaid may be overburdened, with higher-than-average yearly patient volumes. Dr. Jane Zhu, associate professor of medicine at OHSU, joins us with more details.  

Up in the middle of the night at 2:37 a.m. like clockwork? Toss and turn, desperately trying to slip into slumber? Eyes pop open at 4 a.m. though you'd really love to sleep in till at least 6? Are you just tired all the time? Welcome to the sleep syndrome of menopause–a common cluster of midlife sleep problems this week's guest Dr. Andrea Matsumura treats every day. We break down what's behind women's sleep woes, including sleep apnea, lifestyle factors, and of course menopause. She also shares her DREAM Method as a practical framework for getting a solid night's rest.Dr. Andrea Matsumura, MD, MS, FACP, FAASM is a board-certified sleep medicine physician, menopause expert, speaker, and founder of the D.R.E.A.M. Sleep Method™. Known as Sleep Goddess MD, she specializes in helping women optimize sleep, circadian rhythm, and health during midlife. She is board-certified in Internal and Sleep Medicine, trained at the University of Texas Health Science Center at San Antonio and Oregon Health & Science University, and previously built a women-focused sleep consult service at The Oregon Clinic. Dr. Matsumura currently serves as Medical Director at Cascadia Health, is a Fellow of the American Academy of Sleep Medicine, co-founder of the M/Power Menopause Collective, and a leader in the Sleep Is Good Medicine™ campaign. Her work has been featured in The New York Times, SHAPE, SELF, and CNN Underscored. You can learn more about her and her work at andreamatsumuramd.comResourcesYou Deserve to Get Good Sleep with Andrea Matsumura, MD (Episode 91)

Health Affairs' Rob Lott interviews Jane Zhu of Oregon Health & Science University about her recent paper exploring how many physicians enrolled in Medicaid see few or no Medicaid beneficiaries as patients, highlighting a greater need for targeted policies to boost participation and improve access.Order the February 2026 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcast

JOIN ELEVATED GP Follow @dr.melissa_seibert on Instagram   Dr. Dichter brings nearly 20 years of clinical, research and teaching experience — as a general practitioner and prosthodontist — to his position with Spear. He serves as an instructor in the Treating the Terminal Dentition and Fully Edentulous Patient seminar, in addition to multiple Spear Workshops. Dr. Dichter has served as a guest lecturer and clinical instructor at Oregon Health and Science University School of Dentistry, teaching occlusion and esthetics. He has been a Spear faculty member since the company's inception, as well as a contributing author for Spear Digest. He is passionate about education and is involved with multiple study groups in the U.S. and Canada. After earning his D.M.D. from OHSU in 1995, Dr. Dichter practiced general dentistry and eventually joined a startup practice in his hometown in coastal Oregon before moving to a practice in Portland. He brought 16 years of restorative dental experience into UCLA's world-renowned, full-time advanced prosthodontics residency, which he completed in 2014.

Dr. Frank Peacock and Dr. Damon R. Kuehl join BioTalk for a focused discussion on one of emergency medicine's most persistent challenges: accurately diagnosing and predicting outcomes in mild traumatic brain injury. As Scientific Advisory Board members for BrainBox Solutions, Inc., they walk through what happens when a patient presents to the emergency department after a fall or sports injury and why current tools, including CT scans, often leave clinicians without clear answers. The conversation explores the gap between a "normal" scan and ongoing symptoms, and what missed or uncertain diagnoses can mean for patients weeks later.   Dr. Peacock outlines the HeadSMART II study and explains why combining blood biomarkers with neurocognitive testing provides a more complete assessment than biology alone. Dr. Kuehl discusses how multi-modal data, integrated through artificial intelligence, can generate an objective score to support real-time clinical decision-making and help identify patients at risk for persistent symptoms. The episode also highlights BrainBox's leadership, including CEO Donna Edmonds, a member of the BioHealth Innovation Board of Directors, and the company's role in advancing objective mTBI testing.   Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).   Dr. W. Frank Peacock IV is Professor of Emergency Medicine at Baylor College of Medicine. Chief Medical Officer at AseptiScope, and the founder of both a contract research organization called Comprehensive Research Associates, LLC and a medical education company named Emergencies in Medicine, LLC. Dr. Peacock received his medical degree from Wayne State University Medical School and completed his Emergency Medicine training at William Beaumont Hospital. He has >900 peer reviewed publications and is also the co-editor of multiple medical textbooks on heart failure, acute coronary syndromes, and traumatic brain injury.   Dr. Damon R. Kuehl is the Vice Chair of Research and Academic Affairs and Professor in the Department of Emergency Medicine at Virginia Tech, School of Medicine. He completed Medical School at University of Minnesota Medical School and his Emergency Medicine Residency at Stanford University. He has also completed residencies in Preventive Medicine and a Research Fellowship in the Center for Policy and Research in Emergency Medicine, at Oregon Health and Science University. Dr. Kuehl's research primarily focuses on diagnostic and prognostic uncertainty in brain injury. He is a lead investigator for HeadSMART II and for HeadSMART Geriatrics, a NINDS funded 3 year study to develop a diagnostic tool for head trauma in older adults.  He is the founder of the Carilion Brain Injury Center and also an investigator with the Virginia Tech Center for Biomechanics studying the boundary conditions associated with injuries in older adult falls.

In an unprecedented action, a national primate center made a bold move toward ending animal experimentation and becoming a sanctuary.  Amy Meyer, PETA's Associate Director of Primate Experimentation Campaigns, speaks with Emil Guillermo about the signficance of the Oregon Health and Science University's step toward ending monkey experiments at its Oregon National Primate Research Center. Go to PETA.org for more. ---- PETA, the world's largest animal rights organization with all its global entities, is 9 million strong and growing. Hosted by Emil Guillermo. Powered by PETA activism. Contact us at PETA.org. Music provided by CarbonWorks. Go to Apple podcasts and subscribe. Contact and follow host Emil Guillermo on www.YouTube.com/@emilamok1 Please subscribe, rate, and review wherever you get your podcasts. Thanks for listening to THE PETA PODCAST! (Released, 2/11/26   ©copyright 2026        

In an unprecedented action, a national primate center made a bold move toward ending animal experimentation and becoming a sanctuary.  Amy Meyer, PETA's Associate Director of Primate Experimentation Campaigns, speaks with Emil Guillermo about the signficance of the Oregon Health and Science University's step toward ending monkey experiments at its Oregon National Primate Research Center. Go to PETA.org for more. ---- PETA, the world's largest animal rights organization with all its global entities, is 9 million strong and growing. Hosted by Emil Guillermo. Powered by PETA activism. Contact us at PETA.org. Music provided by CarbonWorks. Go to Apple podcasts and subscribe. Contact and follow host Emil Guillermo on www.YouTube.com/@emilamok1 Please subscribe, rate, and review wherever you get your podcasts. Thanks for listening to THE PETA PODCAST! (Released, 2/11/26   ©copyright 2026        

In an unprecedented action, a national primate center made a bold move toward ending animal experimentation and becoming a sanctuary.  Amy Meyer, PETA's Associate Director of Primate Experimentation Campaigns, speaks with Emil Guillermo about the signficance of the Oregon Health and Science University's step toward ending monkey experiments at its Oregon National Primate Research Center. Go to PETA.org for more. ---- PETA, the world's largest animal rights organization with all its global entities, is 9 million strong and growing. Hosted by Emil Guillermo. Powered by PETA activism. Contact us at PETA.org. Music provided by CarbonWorks. Go to Apple podcasts and subscribe. Contact and follow host Emil Guillermo on www.YouTube.com/@emilamok1 Please subscribe, rate, and review wherever you get your podcasts. Thanks for listening to THE PETA PODCAST! (Released, 2/11/26   ©copyright 2026        

 Portland filmmaker Jan Haaken has a new short documentary called “SUMUD: A doctor’s report on genocide and survival in Gaza.” “Sumud” in Arabic means “steadfast perseverance.” The film follows Oregon Health and Science University anesthesiologist Travis Melin as he provided volunteer medical care in Gaza in August of 2025. We’re joined by Haaken and Melin who share more about making the documentary -- and what effect they hope the stories in the film will have.

Hacking The Healthcare System: The Rise Of Subscription-Based DoctorsShould primary care be subscription-based? As the shortage of primary care physicians continues to worsen, many patients are struggling to secure timely appointments within the traditional healthcare system. This week, our expert explores the rise of alternative models that offer quicker access and more personalized attention through membership-based feesGuest: Dr. Jane Zhu, primary care physician, associate professor of medicine, Oregon Health and Science UniversityHost: Elizabeth WestfieldProducer: Kristen Farrah.   The Life-Threatening Link Between Menopause And Heart HealthMenopause is a time of major change in every woman's life, but while many focus on common symptoms like hot flashes, there's a lesser-known threat to long-term heart health. Dr. Priya Freaney reveals the critical importance of recognizing these risks and taking action to reduce the threat of heart disease and heart failure after menopause.Guests: Dr. Priya Freaney, cardiologist, assistant professor of medicine, Northwestern UniversityHost: Greg JohnsonProducers: Kristen Farrah Medical Notes: The New Community Flu Shot, A Better Treatment For Schizophrenia, And How Vitamins Can Protect Male FertilityA breakthrough in mental health treatment is offering new hope for those living with Schizophrenia. Scientists may have found the breakthrough for a flu shot that protects the community. Are vitamins the secret to male fertility? The thrill of the game may be fueling more than just team spirit. Host: Maayan Voss de BettancourtProducer: Kristen Farrah Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The board of directors at Oregon Health & Science University, which runs the primate center, voted unanimously in favor of the move.

In this powerful and wide-ranging episode of The Injured List Podcast, we sit down with two inspiring guests who are using their voices and platforms to make a real impact—on and off the field.We're joined by Sherine Blackford, founder of Loving Loic, a platform dedicated to raising awareness and funding for PKAN, a rare and devastating neurodegenerative disorder. Sherine shares her deeply personal journey, the realities families face navigating rare disease, and how advocacy, community, and purpose can rise from unimaginable challenges.Learn more about the work she's doing — and how you can contribute to the Super Bowl Give-Off fundraiser supporting PKAN research

Hacking The Healthcare System: The Rise Of Subscription-Based DoctorsShould primary care be subscription-based? As the shortage of primary care physicians continues to worsen, many patients are struggling to secure timely appointments within the traditional healthcare system. This week, our expert explores the rise of alternative models that offer quicker access and more personalized attention through membership-based fees.Guests: Dr. Jane Zhu, primary care physician, associate professor of medicine, Oregon Health and Science UniversityHost: Elizabeth WestfieldProducer: Kristen Farrah   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

A new study from Oregon Health & Science University found that air pollution can impact adolescent brain development. The analysis indicated that exposure to common air pollutants is associated with accelerated cortical thinning in areas of the brain responsible for language, mood regulation and socioemotional processing. Researchers observed changes even in children who were exposed to pollution at levels the Environmental Protection Agency considers safe.    Calvin Jara is an otolaryngology resident at OHSU and the study’s lead author. He joins us with more details about how these changes could affect children’s physical and emotional health.

Welcome back for our series on AI for the clinician. This episode is a discussion about the ethical challenges and questions of AI in surgery, and there are often more questions than answers. Hosts: Ayman Ali, MD Ayman Ali is a Behind the Knife fellow and general surgery PGY-4 at Duke Hospital in his academic development time where he focuses on data science, artificial intelligence, and surgery.  Ruchi Thanawala, MD: @Ruchi_TJ Ruchi Thanawala is an Associate Professor of Thoracic Surgery and Faculty in the Informatics Division at Oregon Health and Science University (tOHSU) and founder of Firefly, an AI-driven platform that is built for competency-based medical education. In addition, she directs the Surgical Data and Decision Sciences Lab for the Department of Surgery at OHSU.  Phillip Jenkins, MD: @PhilJenkinsMD Phil Jenkins is a general surgery PGY-4 at Oregon Health and Science University and a National Library of Medicine Post-Doctoral fellow pursuing a master's in clinical informatics.  Steven Bedrick, PhD: @stevenbedrick Steven Bedrick is a machine learning researcher and an Associate Professor in Oregon Health and Science University's Division of Informatics, Clinical Epidemiology, and Translational Data Science. His research is focused on biomedical applications for speech and language technologies, with particular emphases on facilitating secondary use of electronic health record data and on supporting the diagnosis and management of language and communication disorders. Ryan Antiel, MD: @RyanAntiel Ryan Antiel is an Associate Professor of Pediatric Surgery at Duke Hospital and an associate director of the Trent Center for Bioethics, Humanities, and History of Medicine. His research addresses ethical challenges surrounding the care of seriously ill fetuses and neonates. He is also interested in the moral formation of surgical trainees.   Kayte Spector-Bagdady, JD: @KayteSB Kayte Spector-Bagdady is the Wantz Professor of Bioethics and Director of Michigan Bioethics at the University of Michigan Medical School. Her research focuses on increasing accessibility of health data for research and generalizability for diverse patient populations. She is also the former Associate Director for President Obama's bioethics commission. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Big changes are in store for the federal student loan program. President Trump’s tax and spending bill, which was signed into law last summer, ends a supplemental loan for graduate students and caps  the amount they can borrow from the government. It also allows students in professional programs, such as law and medicine, to borrow more than students in other graduate programs, such as nursing or social work.   The bill reduces students’ loan repayment options from seven to two. It also phases out the Biden-era SAVE plan, which was the most flexible income-driven repayment option.         Jennifer Bell is the director of financial aid at Portland State University. Susan Bakewell-Sachs is the vice president of nursing affairs and dean of the School of Nursing at Oregon Health & Science University. They join us to discuss what the changes could mean for students who rely on loans, particularly to get advanced degrees.  

For years now, scientists have shown that daily exposure to bright light therapy, which simulates the intensity of outdoor light, can be beneficial for people with insomnia and other sleep disorders, Seasonal Affective Disorder or other forms of depression. But what if bright light therapy can help people recover from concussions or other traumatic brain injuries? And what if it can also lower the risk of neurodegenerative diseases like Parkinson’s or Alzheimer’s, which people with TBIs are at higher risk for?    Scientists at Oregon Health & Science University were recently awarded a $4 million grant from the U.S. Department of Defense to explore these questions and possibly unlock more secrets about sleep and its effect on health. The OHSU researchers will recruit nearly 120 military veterans who have suffered a TBI. The participants will be given a light box to use at home for one hour each morning for four weeks. Blood samples will be drawn from participants to look for changes in markers that signal inflammation in the brain and changes in oxygen uptake in brain cells.    MRI scans of participants’ brains will also help reveal if the bright light therapy has improved activity of the glymphatic system - a relatively recent discovery about the role of sleep in reducing toxins that can lead to neurodegenerative diseases like Alzheimer’s. Joining us for more details of the study and to share new insights about sleep science is Jonathan Elliott, assistant professor of neurology and co-director of the Sleep & Health Applied Research Program at OHSU.

Allison Lindauer, PhD, APRN joins us to tackle the challenges of navigating behavioral changes caused by Frontotemporal Degeneration (FTD). We talk about some behavior management strategies and the importance of seeking support early and prioritizing your own well-being as a caregiver. Let us know what you think when you listen. - R+MAllison Lindauer is a nationally certified nurse practitioner, researcher, and Associate Director at Oregon Health & Science University's Aging and Alzheimer's Disease Research Center, where she leads outreach and clinical care for families affected by dementia and FTD through her National Institute on Aging–funded STELLA-FTD study.Learn more about the STELLA FTD Study here. A VERY special thank you to today's sponsors ⁠Progranulin Information Navigator⁠ and ⁠Psilera⁠. Want to support the podcast + get more content? Join us on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠! You get exclusive content + a space to share and connect with others. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.patreon.com/remembermecommunity⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you're curious about anything RM, we'd love to connect with you on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram, and visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠our website at⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ www.remembermeftd.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, all the latest updates! Also checkout our new charity foundation for the FTD Community www.remembermefoundation.org------Remember Me Podcast + Community is here to offer hope + human connection for families, caregivers, and individuals impacted by Frontotemporal Dementia (FTD). Always, always accept the good.

Oregon consistently ranks near the bottom of the country in terms of access to treatment for substance use disorders. Portland-based Boulder Care seeks to address that by providing telehealth and medically assisted treatment options. The company launched in 2017 and has been based in Portland since 2019. Its aim is to normalize this kind of treatment and make it available in the first days or hours when a person with substance use disorder decides they want to get help. Dr. Honora Englander, who directs the Improving Addiction Care Team (IMPACT) at Oregon Health and Science University, says access to telehealth and medication for opioid use disorder is an important part of addressing the huge and multifaceted problem of substance use disorder. Englander and Strong both participated in the industry-wide AMERSA conference held in Portland last week, and they join us in studio to discuss more about evidence-based approaches to in-patient and out-patient care for people dealing with addiction.

Jane Zhu is an associate professor of medicine in the Division of General Internal Medicine at Oregon Health and Science University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.M. Zhu and H. Rooke-Ley. Regulating Corporate Control in Health Care — Oregon's Attempt to Revive the CPOM Doctrine. N Engl J Med 2025;393:1972-1974.

This episode explores the essentials of effective doctor-patient communication in today's rapidly changing healthcare landscape, particularly in an era influenced by “Dr. Google” and increased patient access to information. Dr. Katie Schabel, Professor of Orthopaedic Surgery at Oregon Health and Science University, draws from her experience as both a clinician and educator to discuss practical strategies for building trust, demonstrating empathy, and fostering shared decision-making with patients. Topics include the “four E's” of communication - engage, empathize, educate, and enlist - as well as tips for tackling complex conversations around surgical risks, optimization, and misinformation found online. Host: Robert Orfali, MD, Editor in Chief, AAOS NowGuest: Katie Schabel, MD, Professor of Orthopaedic Surgery, Oregon Health and Science University

Episode Description:  Not sure if you should receive a vaccine given your psoriasis or psoriatic arthritis medication?  Dermatologist Dr. Jason Hawkes explores this question along with vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis. Listen as hosts Jeff Brown and LB Herbert discuss key questions about vaccine use and psoriatic disease with dermatologist and NPF Medical Board member Dr. Jason Hawkes who is co-owner, Chief Scientific Officer, and investigator with the Oregon Medical Research Center. Hear what the difference is between live and non-live vaccines, how type of vaccine and immunosuppressive medications impact the timing of vaccines in relation to treatment half-lives. Get your questions answered. The intent of this episode is to offer answers to questions about vaccine use for people with psoriasis and psoriatic arthritis who take immunosuppressive treatments.   Timestamps: (0:23) Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Jason Hawkes. (1:15) In general, what is a vaccine and how it works in the body. (2:08) Will vaccines provide the same level of protection in people with psoriatic disease who are         on treatments that influence the immune system. (4:53) The difference between live and non-live vaccines.   (8:57) Summary of NPF Vaccine Recommendations in relation to live and non-live vaccines and             specific medications for psoriatic disease, including a definition of medication half-lives. (13:38) Vaccines that may be recommended prior to starting a systemic medication or biologic. (18:27) The mRNA vaccine – how it works in comparison to other vaccines. (22:31) How long immunity lasts from childhood vaccines. (25:24) The vaccine guidelines apply to both psoriasis and psoriatic arthritis with some nuances.      (28:38) Which healthcare provider to turn to for advice about vaccines and why. (31:54) Questions to ask your health care provider about vaccines. (33:26) How clinical trials and registries are evolving to assess the effect of vaccines with specific             medications and the need for greater understanding. (36:44) Develop a good relationship with your health care provider and don't be afraid to ask                 questions about your psoriatic disease, vaccines, or specific medications. Key Takeaways: ·       Vaccines work to help protect the body or stimulate protection against common infections or pathogens. There are different types that can be classified as either live or non-live vaccines.   ·       Evidence-based vaccine recommendations are available for people with psoriasis and psoriatic arthritis to help guide timing of when to receive live and non-live vaccines when taking immunosuppressive oral systemic medications and/or biologics.   ·       It's important to discuss which vaccines to consider, and how current psoriasis medication could impact the intended response and timing  with your health care team which includes a primary care physician, a dermatologist, and/or rheumatologist.    Guest Bio: Dermatologist Jason Hawkes, M.D., MS is Co-owner, Chief Scientific Officer and Investigator with Oregon Medical Research Center (OMRC) in Portland, Oregon. He is also a Clinical Assistant Professor of Dermatology at Oregon Health and Science University and the President and Sole Member of Hawkes Dermatology. Prior to joining the Oregon Medical Research Center, Dr. Hawkes held academic faculty appointments in the Departments of Dermatology at the University of Utah School of Medicine, Icahn School of Medicine at Mount Sinai, and University of California-Davis. Dr. Hawkes' principal clinical and research interests are the treatment of complex inflammatory skin diseases, such as psoriasis, hidradenitis suppurativa, chronic urticaria (hives), and eczema. He has a special interest in translational human research and the development of novel biologics and small molecules used for the treatment of inflammatory conditions. Dr. Hawkes is also a Councilor of the International Psoriasis Council (IPC) and serves on the Medical Board and Scientific Advisory Committee of the National Psoriasis Foundation (NPF) where he participates in the development of clinical consensus statements. Resources:         “Does Having Psoriatic Disease Impact Vaccine Choices?” Psound Bytes™ podcast with Dr. Sandy Chat (University of California) and Dr. Christoph Ellebrecht (Dept. of Dermatology, University of Pennsylvania).       Medical Board Clinical Statements                

Text us a comment or question!We're living longer - but not healthier. Chronic disease, obesity, cancer, and cognitive decline are skyrocketing, and most of us have been led to believe it's all about food and fitness. But there's a deeper story hiding in plain sight. In this eye-opening conversation, Coach Kevin English sits down with Dr. Nathan Donley, a cellular biologist turned environmental health researcher, to uncover the truth about the toxins all around us - and inside us. From pesticide-laden crops to chemical-filled water and everyday household products, Dr. Donley reveals how corporate profits and weak policy have created an invisible health crisis. You'll learn what these chemicals are doing to your body, how they interact with diet and lifestyle, and why prevention (not treatment) should be the future of medicine. If you've ever felt like you're doing “everything right” but still struggling to feel vibrant and strong, this episode will change the way you think about health, aging, and personal responsibility. In This Episode You'll Discover:Why chronic disease rates keep climbing - even as science advancesThe shocking truth about what's really in your food, water, and soilHow modern agriculture and corporate lobbying shape the “standard” American dietThe difference between dirt and living soil (and why it matters for your health)How long-term exposure to small amounts of toxins can sabotage your body's ability to healWhy the solution isn't a “detox” - it's systemic change and smarter choicesWhat steps you can take today to reduce exposure and reclaim control over your health About Dr. Nathan DonleyDr. Donley earned his PhD in Cell and Developmental Biology at Oregon Health and Sciences University, where he studied how toxic chemicals damage DNA and lead to cancer. Today, he works with the Center for Biological Diversity, fighting to expose the health and environmental dangers of pesticides and chemical pollution - and pushing for stronger protections for people, wildlife, and the planet.Visit https://www.biologicaldiversity.org to learn more and take action.Instagram - https://www.instagram.com/centerforbiodiv/ 

Imaginez un peu : transformer de simples cellules de peau en ovule.Imagine that: transforming simple skin cells into egg cells.Ouais.Yeah.Et qu'ils puissent être fécondés.And that they can be fertilized.C'est la prouesse que des chercheurs expliquent dans Nature Communications.This is the feat that researchers explain in Nature Communications.C'est potentiellement énorme pour l'infertilité mais ça soulève de sacrées questions.It's potentially huge for infertility but it raises some serious questions.Alors, premier point : la science derrière tout ça.So, first point: the science behind all this.L'équipe de Paula Amato de l'Oregon Health and Science University, eh bien elle a réussi à créer ces ovocytes humains fonctionnels.The team of Paula Amato from the Oregon Health and Science University, well, they succeeded in creating these functional human egg cells.Ils ont même pu être fécondés par des spermatozoïdes.They could even be fertilized by sperm.Bon, ça a donné des embryons, mais ils avaient des anomalies, alors ils ont été détruits, hein.Well, it resulted in embryos, but they had abnormalities, so they were destroyed, you know.Les idées d'application, il y en a : traiter certaines infertilités, permettre aux couples de même sexe d'avoir des enfants génétiquement liés ou pallier le manque de don de gamètes, un vrai sujet en France par exemple.There are ideas for application: treating certain infertilities, allowing same-sex couples to have genetically related children or compensating for the lack of gamete donation, a real issue in France, for example.Mais, attention, hein, Paula Amato le répète, on parle de moins d'une décennie avant d'imaginer utiliser ça en clinique.But, be careful, Paula Amato repeats it, we're talking about less than a decade before considering using this in a clinical setting.On en est vraiment qu'au tout début.We are really only at the very beginning. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Send us a textGenetic & environmental factors that affect brain health, including why people age faster in outer space. (Note: technical difficulties affected the audio quality of this recording somewhat)Episode Summary: Dr. Jacob Raber explains how apolipoproteins, particularly ApoE, influence brain health and disease risk; their role in cholesterol metabolism, Alzheimer's disease, and responses to environmental stressors like radiation and viral infections; interplay between genetics, diet, and lifestyle factors, highlighting how these affect cognitive function and resilience to stress; research into space radiation, the gut-brain axis, and potential interventions for neurodegenerative diseases.About the guest: Jacob Raber, PhD, is a neuroscientist at Oregon Health & Science University (OHSU) in Portland, where he leads a lab studying genetic and environmental influences on brain health, particularly using mouse models with human genes.Discussion Points:Apolipoproteins (ApoE2, E3, E4) are proteins involved in cholesterol and lipid metabolism in the brain, with ApoE4 increasing risks for Alzheimer's and cardiovascular disease.ApoE4 carriers may face higher risks for cognitive decline but could have advantages in specific contexts, like fertility or certain infections.Environmental stressors, such as space radiation and viral infections like West Nile, can exacerbate oxidative stress, impacting brain health.The gut microbiome influences brain function indirectly via the gut-liver-brain axis, with ongoing studies exploring its role in Alzheimer's and traumatic brain injury.Lifestyle factors like diet, exercise, and sleep are critical for brain health, potentially mitigating genetic risks like ApoE4.Statins, commonly used for cholesterol management, may impair learning in healthy animals, suggesting context-dependent effects.Research into space radiation reveals potential therapeutic applications, such as using heavy ion radiation for cancer treatment.Genetic variations, including ethnicity and sex, influence ApoE-related disease risks, with women and certain populations showing higher Alzheimer's susceptibility.Chronic low-level stressors, like air pollution, may pose greater risks to brain health than acute exposures due to insufficient activation of protective mechanisms.Related content:M&M 165: PUFAs in Brain Health & Disease, Dietary Fats, Brain Lipids, Nutrition | Richard Bazinet*Not medical adviceSupport the showAffiliates: Seed Oil Scout: Find restaurants with seed oil-free options, scan food products to see what they're hiding, with this easy-to-use mobile app. KetoCitra—Ketone body BHB + electrolytes formulated for kidney health. Use code MIND20 for 20% off any subscription (cancel anytime) Lumen device to optimize your metabolism for weight loss or athletic performance. Code MIND for 10% off SiPhox Health—Affordable at-home blood testing. Key health markers, visualized & explained. Code TRIKOMES for a 20% discount. For all the ways you can support my efforts

Some people living with MS adhere to a treatment plan based exclusively on what we might consider traditional medicine. Others opt for alternative treatments. And, still, others take a whole-person health approach, blending integrative medicine with traditional treatments designed to support an individual's mind and body. Dr. Lynne Shinto joins me to discuss how a whole-person health approach can transform living with MS. Dr. Shinto is a Professor of Neurology and an MS Specialist at the Center for Women's Health at Oregon Health and Science University.   We're also sharing some encouraging news about funding for the National Institutes of Health in 2026. We'll explain the research that has led to the identification of a new and quite different subtype of MS.  We'll tell you about this year's winner of the Rachel Horne Prize for Women's Research in Multiple Sclerosis. The National MS Society's virtual program, New to MS: Navigating Your Journey, takes place in just two days. We have all the details! We have a lot to talk about! Are you ready for RealTalk MS??! This Week: A whole-person health approach to MS care  :22 House Republicans reject President Trump's $20 billion cut to 2026 NIH funding  1:26 Have researchers identified a new MS subtype?  4:16 This year's winner of the Rachel Horne Prize for Women's Research in Multiple Sclerosis   8:27 We're two days away from the National MS Society's New to MS: Navigating Your Journey virtual program  9:53 Dr. Lynne Shinto discusses how taking a whole-person approach to MS care can transform your MS journey 12:04 Share this episode  31:41 Next week's episode   32:01 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/419 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com PARTICIPATE: Take the Shaping Tomorrow Together Survey https://s.alchemer.com/s3/Perspectives-on-MS REGISTER: Attend the virtual Shaping Tomorrow Together meeting with the FDA https://nmss.quorum.us/event/25463 SIGN UP: Become an MS Activist https://nationalmssociety.org/advocacy STUDY: Large-Scale Online Assessment Uncovers a Distinct Multiple Sclerosis Subtype with Selective Cognitive Impairment https://nature.com/articles/s41467-025-62156-4 REGISTER: New To MS: Navigating Your Journey https://nationalmssociety.org/understanding-ms/newly-diagnosed/new-to-ms-journey Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 419 Guest: Dr. Lynne Shinto Privacy Policy

Welcome back our series on AI for the clinician! In this episode, we go over some basics of machine learning statistics with the goal to help you read and analyze contemporary studies. Some of this will be a review, and parts will be technical, but by the end we hope reading these studies is less daunting.  Hosts: Ayman Ali, MD Ayman Ali is a Behind the Knife fellow and general surgery PGY-4 at Duke Hospital in his academic development time where he focuses on data science, artificial intelligence, and surgery.  Julie Doberne, MD, PhD: @juliedoberne Julie Doberne is an Assistant Professor of Surgery, Assistant Professor of Medical Informatics and Clinical Epidemiology, cardiothoracic surgeon, and faculty member of the Surgical Data and Decision Sciences Lab at Oregon Health and Science University.  Phillip Jenkins, MD: @PhilJenkinsMD Phil Jenkins is a general surgery PGY-4 at Oregon Health and Science University and a National Library of Medicine Post-Doctoral fellow pursuing a master's in clinical informatics.  Steven Bedrick, PhD: @stevenbedrick Steven Bedrick is a machine learning researcher and an Associate Professor in Oregon Health and Science University's Department of Medical Informatics and Clinical Epidemiology.  Shelby Willis, MD Shelby Willis is a general surgery PGY-4 at Oregon Health and Science University. She is currently in her research time in the Surgical Data and Decision Sciences lab at OHSU pursuing advanced training in informatics. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen BTK Fan Favorites:  General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US